Completed PHASE4 INTERVENTIONAL 2-arm NCT00693121

Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State

Amantadine Hydrochloride for Treatment of Symptoms of the Post-traumatic Confusional State Among Neurorehabilitation Admissions With TBI: A Randomized, Double-Blind, Placebo-Controlled Trial

Sponsor: Methodist Rehabilitation Center

Conditions Delirium Posttraumatic Confusional State Traumatic Brain Injury

Interventions Amantadine hydrochloride Placebo capsule

Updated 8 times since 2017 Last updated: Oct 17, 2023 Started: Apr 30, 2003 Primary completion: Nov 30, 2007 Completion: Mar 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Delirium and Posttraumatic Confusional State, this trial is completed. The trial is conducted by Methodist Rehabilitation Center and has accumulated 8 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Nov 2023 — Jul 2024 [monthly]

Completed PHASE4
Jan 2021 — Nov 2023 [monthly]

Completed PHASE4
Sep 2019 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed

▶ Show 3 earlier versions

Jun 2018 — Sep 2019 [monthly]

Unknown Status PHASE4
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE4
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE4

First recorded

Apr 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Methodist Rehabilitation Center
U.S. Department of Education

Data source: Methodist Rehabilitation Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jackson, United States